-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓USDISIN US6323071042
ISIN US6323071042
WKN A14VPJ
Symbol NTRA
Währung
USD
Firmenname
Natera, Inc
Marktkapitalisierung
9.607.800.800 (+- 10%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
10.616.601.600 oder 8.599.000.000
Mitarbeiter
1.999 (+- 48%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
1.039 oder 2.958 Mitarbeiter
EBITDA -107.001.000
Buchwert 6.285
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 82,81 USD -0,80%
Portrait der Natera Aktie
Das Unternehmen Natera, Inc aus USA beschäftigt 1.999 Mitarbeiter.
Das Unternehmen Natera, Inc ist nur in 9 ETFs enthalten und somit eine nicht sonderlich bekannte oder beliebte Aktie. Der Spitzenreiter Global X Genomics & Biotechnology ETF gewichtet Natera mit 3,90% im ETF.
Entdecke die 6 ETFs in denen Natera, Inc am höchsten gewichtet ist Insgesamt in 9 ETFs enthalten
Dir gefallen die Informationen zu Natera?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Natera?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Natera?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Natera?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
36 News & Informationen zur Natera Aktie
SomaLogic expands leadership team with new positions to drive commercial success
NEW YORK and BOULDER, Colo., Aug. 31, 2021 (GLOBE NEWSWIRE) — CM Life Sciences II (NASDAQ: CMIIU) and SomaLogic, a leader in AI data-driven proteomics…
Sculptor Capital LP Buys Nuance Communications Inc, Microsoft Corp, Natera Inc, Sells , Apple Inc,
GuruFocus Article or News written by insider and the topic is about:
Frontier Capital Management Co Llc Buys NovoCure, Signify Health Inc, Natera Inc, Sells Nuance Communications Inc, Magnite Inc, Vulcan Materials Co
GuruFocus Article or News written by insider and the topic is about:
5 Dividend Funds Yielding Up To 27.2%
Double-digit dividends are rare. A sky-high yield of 27.2% is an outright income unicorn.
How to Get 7.3%-27.2% Yields (For Up to 10% Off, Too!) – The Contrary Investing Report
Here is a Market Recap for today Monday, August 9, 2021 : StockMarket
PsychoMarket Recap – Monday, August 9, 2021 Stocks finished mixed today, with the S&P 500 (SPY) and Dow Jones (DIA) both pulling back from all-time …
Natera, Inc. 2021 Q2 – Results – Earnings Call Presentation (NASDAQ:NTRA)
The following slide deck was published by Natera, Inc.
Natera, Inc. (NTRA) CEO Steve Chapman on Q2 2021 Results – Earnings Call Transcript
Natera, Inc. (NASDAQ:NTRA) Q2 2021 Earnings Conference Call August 5, 2021 04:30 PM ET Company Participants Michael Brophy – Chief Financial Officer Steve Chapman – Chief Executive Officer…
Natera (NTRA) Reports Q2 Loss, Tops Revenue Estimates
Natera (NTRA) delivered earnings and revenue surprises of -25.71% and 1.09%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Earnings Scheduled For August 5, 2021
Companies Reporting Before The Bell
• OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of …
Natera Q2 2021 Earnings Preview (NASDAQ:NTRA)
Natera (NASDAQ:NTRA) is scheduled to announce Q2 earnings results on Thursday, August 5th, after market close.The consensus EPS Estimate is -$1.20 (-60.0% Y/Y) and the consensus…
Cancer Biopsy Market Size To Reach $44.51 Billion By 2027 | CAGR: 11.13%: Grand View Research, Inc.
SAN FRANCISCO, July 29, 2021/PRNewswire/ — The global cancer biopsy market size is expected to reach USD 44.51 billion by 2027, according to a ne…
Mixed Session as Fed, Earnings Compete For Market’s Attention
Stocks Analysis by Zacks Investment Research covering: Microsoft Corporation, Alphabet Inc Class A, Apple Inc, Amazon.com Inc. Read Zacks Investment Research's latest article on Investing.com
3 Stocks Insiders Are Buying
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this …
Natera : Launches Proposed Follow-On Offering (Form 8-K)
Natera Launches Proposed Follow-On Offering
AUSTIN, Texas, July 20, 2021-Natera, Inc. , a pioneer and global leader in cell-free DNA testing, today announced the launch of a… | July 22, 2021
Here is What Hedge Funds Think About Albertsons Companies, Inc. (ACI)
As we already know from media reports and hedge fund investor letters, hedge funds delivered their best returns in a decade. Most investors who decided…
Natera launches follow-on offering of $350M shares
(NASDAQ:NTRA)
Genetic test maker Natera has launched a follow-on public offering of $350M common shares.The company expects to grant a 30-day option for underwriters to buy another $52.5M of shares…
Natera Launches Proposed Follow-On Offering
AUSTIN, Texas, July 20, 2021 /PRNewswire/ — Natera, Inc. (Nasdaq: NTRA) (“Natera”), a pioneer and global leader in cell-free DNA testing, today announced the
Should I Avoid Zions Bancorporation, National Association (ZION)?
In this article we will check out the progression of hedge fund sentiment towards Zions Bancorporation, National Association (NASDAQ:ZION) and determine…
Compagnie Lombard, Odier SCA Buys Salesforce.com Inc, BlackRock Inc, Sea, Sells Intellia Therapeutics Inc, Tandem Diabetes Care Inc, Exact Sciences Corp
GuruFocus Article or News written by insider and the topic is about:
Robert Half International Inc. (RHI): Hedge Fund Sentiment Unchanged
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first…
Avitas Wealth Management LLC Buys Marathon Petroleum Corp, Signature Bank, Freeport-McMoRan Inc, Sells Best Buy Co Inc, Autodesk Inc, Delta Air Lines Inc
GuruFocus Article or News written by insider and the topic is about:
Natera Inc (NTRA) CEO AND PRESIDENT Steven Leonard Chapman Sold $3.8 million of Shares
GuruFocus Article or News written by insider and the topic is about:
Natera : New Results From the Landmark Prospective CIRCULATE Trial Expand Clinical Utility of the Signatera® MRD Test in Colorectal Cancer
AUSTIN, Texas, July 2, 2021 /PRNewswire/ — Natera, Inc. , a pioneer and global leader in cell-free DNA testing, today announced it will present new data on its personalized and tumor-informed… | July 2, 2021
New Results From the Landmark Prospective CIRCULATE Trial Expand Clinical Utility of the Signatera® MRD Test in Colorectal Cancer
AUSTIN, Texas, July 2, 2021 /PRNewswire/ — Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced it …
This Explosive Biotech Is Taking On a Huge New Market
Dominant in its core reproductive health market, niche medical diagnostics company Natera now has its sights on the crowded oncology diagnostics space.
Global Genetic Testing Market to Reach $17.3 Billion by 2026
SAN FRANCISCO, June 29, 2021 /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research comp…
Natera : and BGI Genomics Announce Commercial Launch of the BGI/Natera Signatera Assay in China
AUSTIN, Texas and SHENZHEN, China, June 24, 2021 /PRNewswire/ — Natera, Inc. , a pioneer and global leader in cell-free DNA testing, and BGI Genomics Co., Ltd., one of the world's… | June 24, 2021
4 Trending Health Care Stocks To Watch Right Now
Could these health care stocks maintain their growth momentum?
Natera Inc (NTRA) CEO AND PRESIDENT Steven Leonard Chapman Sold $4.3 million of Shares
Natera Inc (NTRA) CEO AND PRESIDENT Steven Leonard Chapman Sold $4.3 million of Shares, Stocks: NTRA, release date:Apr 14, 2021
Stocks That Hit 52-Week Highs On Friday
This morning 150 companies reached new 52-week highs.
Interesting Points: Eli Lilly (NYSE:LLY) was the largest firm by market cap to set a new …
The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Jan. 14) 10X …
Liberty All-Star® Growth Fund, Inc. December 2020 Monthly Update
BOSTON, Jan. 14, 2021 /PRNewswire/ — Below is the December 2020 Monthly Update for the Liberty All-Star Growth Fund, Inc. (NYSE:ASG) Liberty All-Star …
Stocks That Hit 52-Week Highs On Thursday
Before 10 a.m. ET Thursday, 503 stocks hit new 52-week highs.
Noteworthy Points: Taiwan Semiconductor (NYSE:TSM) was the largest firm on a …
The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Ja…
These Were the 5 Best Diagnostics Stocks of 2020
These winners are positioned for gains even after COVID.